MCID: CRD118
MIFTS: 44

Cardiovascular Cancer malady

Categories: Cancer diseases, Cardiovascular diseases

Aliases & Classifications for Cardiovascular Cancer

Aliases & Descriptions for Cardiovascular Cancer:

Name: Cardiovascular Cancer 12 52 14
Cardiovascular Neoplasm 12 69
Cardiovascular Tumors 12

Classifications:



External Ids:

Disease Ontology 12 DOID:176
NCIt 47 C4784
UMLS 69 C0497243

Summaries for Cardiovascular Cancer

Disease Ontology : 12 An organ system cancer that located in the heart and blood vessels.

MalaCards based summary : Cardiovascular Cancer, also known as cardiovascular neoplasm, is related to vascular cancer and heart cancer. An important gene associated with Cardiovascular Cancer is HBA1 (Hemoglobin Subunit Alpha 1), and among its related pathways/superpathways are Glioma and Ras signaling pathway. The drugs Estradiol and Medroxyprogesterone acetate have been mentioned in the context of this disorder. Affiliated tissues include heart and the heart, and related phenotypes are behavior/neurological and growth/size/body region

Related Diseases for Cardiovascular Cancer

Diseases related to Cardiovascular Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 71)
id Related Disease Score Top Affiliating Genes
1 vascular cancer 10.7
2 heart cancer 10.7
3 vasculogenic impotence 10.3 CAMTA1 HBA1
4 alzheimer's disease 11 10.3 HBA1 TSC2
5 arrhythmogenic right ventricular dysplasia 3 10.3 HBA1 KDR
6 thyroid angiosarcoma 10.2 HBA1 VEGFA
7 phencyclidine abuse 10.2 FLT4 HBA1
8 skin angiosarcoma 10.2 HBA1 KIT
9 gapo syndrome 10.2 FLT4 KDR
10 impaired renal function disease 10.2 HBA1 PTH1R TSC2
11 eosinophilic pneumonia 10.2 FLT4 KDR
12 laryngeal adenoid cystic carcinoma 10.2 HBA1 VEGFA
13 corneal dystrophy 10.2 FLT4 SLC2A1
14 keratosis follicularis spinulosa decalvans 10.2 FLT4 KDR
15 alcohol-induced mental disorder 10.2 HBA1 KDR KIT
16 hand, foot and mouth disease 10.2 KDR VEGFA
17 intracranial cysts 10.2 FLT4 VEGFA
18 aniridia - ptosis - intellectual disability - familial obesity 10.2 KDR MME
19 hemiplegic migraine 10.1 CAMTA1 FLT4 KDR
20 cone-rod dystrophy 17 10.1 KDR VEGFA
21 neuropathy with hearing impairment 10.1 CAMTA1 KDR VEGFA
22 neurilemmoma of the pleura 10.1 HBA1 KDR VEGFA
23 pilocytic astrocytoma 10.1 SYP TSC2
24 gestational choriocarcinoma 10.1 HBA1 KIT VEGFA
25 vernal conjunctivitis 10.1 HBA1 KDR VEGFA
26 liver angiosarcoma 10.1 KIT MME
27 breast apocrine carcinoma 10.1 MITF VEGFA
28 renal adenoma 10.1 FLT4 HBA1 VEGFA
29 monkeypox 10.1 KIT SYP
30 gallbladder cancer 10.1 KIT MME TSC2
31 uterine hypoplasia 10.1 KIT MME
32 heavy chain disease 10.1 HBA1 MME SLC2A1
33 kidney osteogenic sarcoma 10.1 KDR SLC2A1 VEGFA
34 gangliosidosis gm1 10.1 KIT MITF TSC2
35 acromegaly 10.1 HBA1 MME
36 microsporidiosis 10.1 HBA1 KIT SYP
37 generalized eruptive keratoacanthoma 10.1 MITF MME
38 intrahepatic bile duct adenoma 10.1 MME SYP
39 benign familial neonatal epilepsy 10.1 FLT4 KDR VEGFA
40 metagonimiasis 10.1 FLT4 KDR VEGFA
41 ampullary signet ring cell adenocarcinoma 10.1 MME SYP
42 saethre-chotzen syndrome 10.0 FLT4 KDR VEGFA
43 verrucous papilloma 10.0 KIT MITF
44 paranasal sinus cancer 10.0 KIT MME
45 sarcomatoid renal cell carcinoma 10.0 KDR MME VEGFA
46 main bronchus cancer 10.0 SYP VEGFA
47 intracranial hypotension 10.0 HBA1 KDR SLC2A1 VEGFA
48 thyroid carcinoma, papillary, with papillary renal neoplasia 10.0 KIT MITF MME
49 glomus tumor 10.0 KIT MITF SYP
50 t-cell adult acute lymphocytic leukemia 10.0 MME SYP TSC2

Graphical network of the top 20 diseases related to Cardiovascular Cancer:



Diseases related to Cardiovascular Cancer

Symptoms & Phenotypes for Cardiovascular Cancer

MGI Mouse Phenotypes related to Cardiovascular Cancer:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.11 CAMTA1 KDR KIT MITF PTH1R SLC2A1
2 growth/size/body region MP:0005378 10.1 CAMTA1 CTSK FLT4 KDR KIT MITF
3 homeostasis/metabolism MP:0005376 10.07 CTSK FLT4 KDR KIT MITF MME
4 embryo MP:0005380 10.03 FLT4 KDR KIT MITF PTH1R SLC2A1
5 integument MP:0010771 9.87 FLT4 KDR KIT MITF MME TSC2
6 nervous system MP:0003631 9.81 TSC2 VEGFA CAMTA1 CTSK KDR KIT
7 liver/biliary system MP:0005370 9.73 FLT4 KDR KIT MME TSC2 VEGFA
8 no phenotypic analysis MP:0003012 9.43 MITF SLC2A1 VEGFA FLT4 KDR KIT
9 normal MP:0002873 9.23 TSC2 VEGFA CAMTA1 FLT4 KDR KIT

Drugs & Therapeutics for Cardiovascular Cancer

Drugs for Cardiovascular Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1167)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-28-2 5757 53477783
2
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 3 71-58-9
3
Progesterone Approved, Vet_approved Phase 4,Phase 3 57-83-0 5994
4
Amiloride Approved Phase 4 2016-88-8, 2609-46-3 16231
5
Amlodipine Approved Phase 4 88150-42-9 2162
6
Simvastatin Approved Phase 4,Phase 3,Phase 2,Early Phase 1 79902-63-9 54454
7
Telmisartan Approved, Investigational Phase 4,Phase 3 144701-48-4 65999
8
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
9
Acetaminophen Approved Phase 4,Phase 2,Phase 1 103-90-2 1983
10
Bupivacaine Approved, Investigational Phase 4,Phase 1 2180-92-9, 38396-39-3 2474
11
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
12
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2 437-38-7 3345
13
Ketorolac Approved Phase 4,Phase 1 74103-06-3, 66635-83-4 3826
14
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
15
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 2078-54-8 4943
16
Pantoprazole Approved Phase 4 102625-70-7 4679
17
Ticlopidine Approved Phase 4 55142-85-3 5472
18
Basiliximab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 152923-56-3, 179045-86-4
19
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
20
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79217-60-0, 59865-13-3 5284373 6435893
21
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
22
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
23
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
24
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 128794-94-5 5281078
25
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 24280-93-1 446541
26
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
27
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
28
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9041-08-1
29
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 772 46507594
30
Levobupivacaine Approved Phase 4 27262-47-1 92253
31
Lidocaine Approved, Vet_approved Phase 4,Phase 3 137-58-6 3676
32
Midazolam Approved, Illicit Phase 4,Phase 2,Phase 1 59467-70-8 4192
33
Amiodarone Approved, Investigational Phase 4,Phase 3 1951-25-3 2157
34
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
35
Tenofovir Approved, Investigational Phase 4 147127-20-6 464205
36
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
37
Pioglitazone Approved, Investigational Phase 4,Phase 1,Phase 2 111025-46-8 4829
38
Cortisone acetate Approved Phase 4,Phase 2 1950-04-4, 50-04-4 5745
39
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 5754 657311
40
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
41
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-61-6, 62-31-7 681
42
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 104987-11-3 445643 439492
43
Bortezomib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 179324-69-7 387447 93860
44
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
45
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 23214-92-8 31703
46
Lisinopril Approved, Investigational Phase 4,Phase 2 83915-83-7 5362119
47
Azathioprine Approved Phase 4,Phase 2,Phase 3,Early Phase 1 446-86-6 2265
48
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
49
Epirubicin Approved Phase 4,Phase 3,Phase 2 56420-45-2 41867
50
Zoledronic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 118072-93-8 68740

Interventional clinical trials:

(show top 50) (show all 3917)
id Name Status NCT ID Phase
1 Multi-centre Clinical Trial on Hormone Replacement Treatment in China Unknown status NCT01698164 Phase 4
2 Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients Unknown status NCT01011660 Phase 4
3 The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin Unknown status NCT01549418 Phase 4
4 Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia Unknown status NCT02103946 Phase 4
5 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4
6 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4
7 Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation Unknown status NCT00903188 Phase 4
8 Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis Unknown status NCT00450645 Phase 4
9 Quadratus Lumborum Block for Percutaneous Nephrostomy Unknown status NCT02121951 Phase 4
10 Vitamin D and Glucose Metabolism in Pediatrics Unknown status NCT01386736 Phase 4
11 Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Unknown status NCT00724581 Phase 4
12 HIV Persistence and Viral Reservoirs Unknown status NCT01025427 Phase 4
13 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4
14 Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy Unknown status NCT01175486 Phase 4
15 Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL Unknown status NCT00300365 Phase 4
16 Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis Unknown status NCT01350206 Phase 4
17 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Unknown status NCT01595750 Phase 4
18 Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM) Unknown status NCT02277587 Phase 4
19 The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism Unknown status NCT00451672 Phase 4
20 Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen Unknown status NCT01560572 Phase 4
21 Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma Unknown status NCT01249690 Phase 4
22 Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension Unknown status NCT02184858 Phase 4
23 Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function Unknown status NCT00541814 Phase 4
24 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT01246310 Phase 4
25 A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma Unknown status NCT01868828 Phase 4
26 Stage I Multiple Myeloma Treatment Unknown status NCT00733538 Phase 4
27 Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin Unknown status NCT02443064 Phase 4
28 Pseudohyponatremia of Multiple Myeloma is True Hyponatremia Unknown status NCT01425606 Phase 4
29 Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia Unknown status NCT01449253 Phase 4
30 Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices Unknown status NCT01970748 Phase 4
31 Oral Contraceptive and Cardiovascular Risk in PCOS Completed NCT00593294 Phase 4
32 An Alternative to A Fixed Schedule In Management Of Prostate Cancer Completed NCT01056562 Phase 4
33 Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis Completed NCT00432406 Phase 4
34 Radical Prostatectomy and Perioperative Fluid Therapy Completed NCT00771966 Phase 4
35 Effect of 5 Years of GH Replacement on Atherosclerosis Completed NCT00462475 Phase 4
36 Ulinastatin's Anti-inflammatory Reaction in Cardiac Surgery Completed NCT01518569 Phase 4
37 Protective Effect of EPA on Cardiovascular Events Completed NCT00231738 Phase 4
38 Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women Completed NCT01048606 Phase 4
39 Hydroxyethyl Starch and Renal Function After Radical Prostatectomy Completed NCT01486563 Phase 4
40 Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization Completed NCT02368054 Phase 4
41 Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure Completed NCT00732693 Phase 4
42 Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly Completed NCT00461149 Phase 4
43 Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers Completed NCT01907373 Phase 4
44 Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus Completed NCT00982358 Phase 4
45 C-Reactive Protein (CRP) in Obese Diabetic Women Completed NCT00262548 Phase 4
46 Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) Completed NCT01708850 Phase 4
47 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Completed NCT01132274 Phase 4
48 Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer Completed NCT01989845 Phase 4
49 Vitamin D Repletion in Stone Formers With Hypercalciuria Completed NCT01295879 Phase 4
50 Development of Active Safety Surveillance System for Traditional Chinese Medicine Completed NCT00275964 Phase 4

Search NIH Clinical Center for Cardiovascular Cancer

Genetic Tests for Cardiovascular Cancer

Anatomical Context for Cardiovascular Cancer

MalaCards organs/tissues related to Cardiovascular Cancer:

39
Heart

The Foundational Model of Anatomy Ontology organs/tissues related to Cardiovascular Cancer:

18
The Heart

Publications for Cardiovascular Cancer

Articles related to Cardiovascular Cancer:

id Title Authors Year
1
Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. ( 23446902 )
2013
2
Tocotrienols: potential drug targets for cardiovascular, cancer and neurological diseases. ( 21774777 )
2011
3
Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. ( 17136506 )
2007
4
On the relationship between all-cause, cardiovascular, cancer and residual mortality rates with age. ( 15785305 )
2005
5
The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. ( 15724141 )
2005
6
Hillcrest Hospital campaigns in competitive Cleveland. Focus is on cardiovascular, cancer and pediatrics. ( 11467198 )
2001
7
The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study) ( 10637085 )
2000

Variations for Cardiovascular Cancer

Expression for Cardiovascular Cancer

Search GEO for disease gene expression data for Cardiovascular Cancer.

Pathways for Cardiovascular Cancer

Pathways related to Cardiovascular Cancer according to GeneCards Suite gene sharing:

(show all 14)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.59 FLT4 KDR KIT MITF TSC2 VEGFA
2
Show member pathways
12.45 FLT4 KDR KIT VEGFA
3 12.37 KIT MITF SLC2A1 VEGFA
4
Show member pathways
11.93 FLT4 KDR TSC2
5 11.89 FLT4 KDR KIT TSC2 VEGFA
6 11.82 FLT4 KDR KIT
7 11.76 KDR MITF VEGFA
8
Show member pathways
11.57 FLT4 KDR VEGFA
9
Show member pathways
11.5 FLT4 KDR KIT
10 11.45 SLC2A1 SYP VEGFA
11
Show member pathways
11.35 FLT4 KDR KIT
12 10.9 KDR VEGFA
13 10.86 KDR SLC2A1 VEGFA
14
Show member pathways
10 FLT4 KDR VEGFA

GO Terms for Cardiovascular Cancer

Cellular components related to Cardiovascular Cancer according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 neuron projection terminus GO:0044306 8.62 MME SYP

Biological processes related to Cardiovascular Cancer according to GeneCards Suite gene sharing:

(show all 21)
id Name GO ID Score Top Affiliating Genes
1 protein autophosphorylation GO:0046777 9.77 FLT4 KDR KIT
2 peptidyl-tyrosine phosphorylation GO:0018108 9.77 FLT4 KDR KIT
3 positive regulation of protein phosphorylation GO:0001934 9.75 FLT4 KDR VEGFA
4 regulation of cell shape GO:0008360 9.72 KDR KIT VEGFA
5 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.7 FLT4 KDR KIT
6 positive regulation of cell proliferation GO:0008284 9.65 FLT4 KDR KIT PTH1R VEGFA
7 positive regulation of MAPK cascade GO:0043410 9.63 FLT4 KDR KIT
8 positive regulation of macroautophagy GO:0016239 9.58 KDR TSC2
9 vascular endothelial growth factor receptor signaling pathway GO:0048010 9.58 FLT4 KDR VEGFA
10 positive regulation of focal adhesion assembly GO:0051894 9.57 KDR VEGFA
11 bone resorption GO:0045453 9.56 CTSK PTH1R
12 melanocyte differentiation GO:0030318 9.54 KIT MITF
13 positive regulation of endothelial cell proliferation GO:0001938 9.54 FLT4 KDR VEGFA
14 embryonic hemopoiesis GO:0035162 9.51 KDR KIT
15 cell migration involved in sprouting angiogenesis GO:0002042 9.49 KDR VEGFA
16 positive regulation of positive chemotaxis GO:0050927 9.48 KDR VEGFA
17 positive regulation of protein kinase C signaling GO:0090037 9.43 FLT4 VEGFA
18 vascular endothelial growth factor signaling pathway GO:0038084 9.32 FLT4 KDR
19 positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway GO:0038033 9.16 KDR VEGFA
20 positive regulation of endothelial cell migration GO:0010595 9.13 FLT4 KDR VEGFA
21 cellular response to vascular endothelial growth factor stimulus GO:0035924 8.8 FLT4 KDR VEGFA

Molecular functions related to Cardiovascular Cancer according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein tyrosine kinase activity GO:0004713 9.5 FLT4 KDR KIT
2 fibronectin binding GO:0001968 9.37 CTSK VEGFA
3 signal transducer, downstream of receptor, with protein tyrosine kinase activity GO:0004716 9.26 KDR KIT
4 vascular endothelial growth factor-activated receptor activity GO:0005021 9.16 FLT4 KDR
5 protein self-association GO:0043621 9.13 PTH1R SLC2A1 SYP
6 transmembrane receptor protein tyrosine kinase activity GO:0004714 8.8 FLT4 KDR KIT

Sources for Cardiovascular Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....